CellGenTech is a Therapeutics Company. CellGenTech is currently exploring opportunities for alliances to advance the development of gene/cell therapy using Pre-Adipocytes Technology. We are now performing the translational clinical research for LCAT deficiency as the 1st target and trying to expand this new therapy to other rare diseases.